Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Watchlist
Price: 33.42 AUD 0.21% Market Closed
Market Cap: AU$19.6B

Net Margin

20.2%
Current
Improving
by 5.7%
vs 3-y average of 14.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
20.2%
=
Net Income
NZ$437m
/
Revenue
NZ$2.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
20.2%
=
Net Income
AU$437m
/
Revenue
NZ$2.2B

Peer Comparison

Country Company Market Cap Net
Margin
NZ
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
22.6B NZD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.6B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.9B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.1B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.7B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.5B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.4B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Higher than 90% of companies in New Zealand
Percentile
90th
Based on 309 companies
90th percentile
20.2%
Low
-2 988.2% — -2.1%
Typical Range
-2.1% — 9.4%
High
9.4% — 106.9%
Distribution Statistics
New Zealand
Min -2 988.2%
30th Percentile -2.1%
Median 4.2%
70th Percentile 9.4%
Max 106.9%

Fisher & Paykel Healthcare Corporation Ltd
Glance View

Nestled in the heart of New Zealand, Fisher & Paykel Healthcare Corporation Ltd. has emerged as a formidable player in the global healthcare market, largely due to its innovative spirit and relentless focus on respiratory care solutions. Originally part of Fisher & Paykel Industries, the healthcare division carved its own path in 2001, quickly becoming synonymous with high-quality medical devices. The company’s journey can be compared to a constant rhythm of innovation, particularly in areas that address obstructive sleep apnea, acute respiratory distress, and surgical humidification. Its revenue streams are primarily bolstered by a diverse array of products, including sleep apnea masks, humidifier systems for intensive care units, and related respiratory accessories. These offerings are not just technological marvels but are designed to improve patient outcomes and their quality of life, which resonates well with healthcare providers worldwide. Over the years, Fisher & Paykel Healthcare has strategically expanded its operations beyond its Kiwi roots, anchoring its presence in over 120 countries. This global footprint, coupled with a robust pipeline of patented products, enables sustained revenue growth and stability. The company’s financial health is driven by a business model that emphasizes research and development, ensuring that it remains at the forefront of medical innovation. By fostering close relationships with healthcare professionals and institutions, Fisher & Paykel not only gains invaluable insights to refine its products but also cultivates a loyal customer base. This enduring approach cements its position not only as a leader in the healthcare sector but also as a trusted partner in the critical mission to enhance patient care worldwide.

FPH Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
20.2%
=
Net Income
NZ$437m
/
Revenue
NZ$2.2B
What is Fisher & Paykel Healthcare Corporation Ltd's current Net Margin?

The current Net Margin for Fisher & Paykel Healthcare Corporation Ltd is 20.2%, which is above its 3-year median of 14.5%.

How has Net Margin changed over time?

Over the last 3 years, Fisher & Paykel Healthcare Corporation Ltd’s Net Margin has increased from 17% to 20.2%. During this period, it reached a low of 7.6% on Mar 31, 2024 and a high of 20.2% on Sep 30, 2025.

Back to Top